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Summary Unrestrained growth of various malignant tumours has been shown to depend upon a critical
number of tumour cells which have switched to the angiogenic phenotype. Angiogenic phenotypes were noted
in the early stage of prostatic carcinoma (PCa). We investigated 65 cases of latent PCa to define the
correlation between tumour angiogenesis and tumour volume. Tumour angiogenesis was determined by the
blood capillary density ratio (BCDR) evaluated by a colour image analysis system. Using experimental
regression analysis, the correlation between the BCDR and PCa volume was divisible into two distinct stages.
When the PCa showed a volume of more than 83 mm3, there was a significant positive correlation between the
BCDR and PCa volume (rS-test P<0.001). However, when the PCa showed a volume of less than 83 mm3,
the BCDR remained at a low level which did not change until larger volumes were present (rS-test, NS;
ANOVA, NS). The present study suggested that latent PCa showing a volume of less than 83 mm3 would be
'early' indolent carcinoma which, on undergoing additional events concerning tumour angiogenesis, would
assume more aggressive growth.
Prostatic carcinoma (PCa) is one of the commonest cancers
in males, and there is an increasing incidence of PCa in a
number of countries (Scardino, 1989). For every case of
clinically apparent PCa, there are many cases of clinically
non-apparent carcinoma, so-called 'latent PCa', which have
historically been discovered at autopsy. The latent PCa have
been considered an early stage of PCa (Scardino, 1989).
Angiogenesis is an important factor in the progression and
enlargement of tumours, and it has been suggested that many
malignant tumours could be assigned to two distinct
phenotypic phases of tumour progression: prevascular and
vascular (Revesz et al., 1989; Barnhill et al., 1992; Bosari et
al., 1992; Brawer et al., 1992; Folkman et al., 1992; Mac-
chiarini et al., 1992; Bigler et al., 1993). The prevascular
phase may persist for years, and is usually associated with
limited tumour growth. On the other hand, the vascular
phase is usually followed by rapid tumour growth and
bleeding.
Recently, we also demonstrated that tumour angiogenesis
was related to tumour growth and the metastatic potential of
the clinical, vascular phase, PCa (Wakui et al., 1992). How-
ever, the question of when the transition to an angiogenic
state occurs during early PCa development in situ has not
been elucidated. We have studied the quantitative mor-
phometry of the angiogenesis of the latent PCa with partic-
ular reference to tumour volume because there is a growing
need for better prognostic indicators for these tumours.
Materials and methods
Sixty-five cases of latent PCa were obtained at autopsy. All
specimens were fixed in 10% buffered formalin for 3-4 days,
and cut in series at 3 mm intervals in transverse planes
perpendicular to the rectal surface. After dehydration in
graded alcohols, the tissues were embedded in paraffin. For
histological evaluation, 4-gLm-thick sections were cut and
stained with Mayer's haematoxylin and eosin. The tumours
were classified according to Gleason's grading system
(Gleason et al., 1974). Patterns of tumour growth were
numbered in order of increasing histological malignancy,
grades 1-5. In each case, a predominant and a secondary
pattern grade were also recorded. The sum of the two grades
yielded a Gleason's score that ranged from 2 to 10. In this
study, scores of 2-4 were classified as low, 5-7 as
intermediate and 8-10 as high.
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For identification of microvascular structures, 4-1tm-thick
sections were cut and stained for vimentin (employing a
monoclonal antibody to vimentin from Amersham), using the
ABC immunoperoxidase method (Osborn & Debus, 1984).
All specimens which stained for vimentin were examined by a
colour image analyser computer system (Olympus-Avio
SP500, Olympus Optical). In order to examine the degree of
angiogenesis of PCa, the blood capillary density ratio
(BCDR) was obtained as the ratio calculated between the
blood capillary area and the tumour area minus the luminal
area of tumour glands. We examined the entire tumour area
in each section, and also the BCDR of a normal prostate
using the same procedure. A full description of the quan-
titative morphology and the image analysis technique has
been described previously (Wakui et al., 1992).
For evaluation of tumour volume, the total area of PCa on
the map was determined by computer planimetry (Video
Micro Meter VM-30, Olympus Optical) and multiplied by the
section thickness, 3 mm (McNeal et al., 1990). Calculated
volume was multiplied by a factor of 1.1 to correct for tissue
shrinkage in processing.
The experimental regression analysis, the analysis of
variance, the X2-test and the rS-test were employed for stati-
stical analysis using statistical analysis computer systems,
Stat Flex (View Flex) and Stat View 4.0 (Abacus Concepts).
Results
The univariate scattergrams of the BCDR and PCa volume
revealed quadratic increasing curved lines (Figure 1).
A significant number of small-volume PCa showed low
scores, and high and intermediate score PCa increased in
number following tumour growth (X2-test: P<0.001) (Table
I). The correlation between the BCDR and PCa volume,
however, was not significantly different for any of the his-
tological grading scores (Figure 2).
By experimental regression analysis, at a PCa volume of
83.125 ± 0.625 mm3, the correlation between the BCDR and
PCa volume could be divided into two distinct phenotypic
stages (Figure 3 and Table II). When the PCa showed a
volume of more than 83.125 ± 0.625 mm3, there was a
significant positive correlation between the BCDR and PCa
volume (rS-test: P<0.001) (Figure 3 and Table II). When
the PCa showed a volume of less than 83.125 ± 0.625 mm3,
there was no correlation between the BCDR and PCa
volume (rS-test: NS) (Figure 3). An insignificant difference
was revealed between each BCDR (ANOVA: NS), and the
Br. J. Cancer (1994), 70, 1244-1246 '." Macmillan Press Ltd., 1994ANGIOGENESIS IN LATENT PROSTATIC CARCINOMA 1245
a
BCDR (%) ± s.e.m.
A
C.)
tt"MMTIVIVM
?TTTI?
Observations
b
PCa volume (mm3)
0
*
0.
S.
2.0
1.8
1.6
1.4
1.2
1.0*
0.8
0.6
0.4
0.2
0
0
0 6
A o0 0
OdAA
1 01
C&A
AS t
a
0 100 200 300 400 500 600 700 800 900 1,0001,100
PCa volume (mm3)
Figure 2 The bivariate scattergram between BCDR and PCa
volume. The correlation between BCDR and PCa volume is
insignificant for any of the histological grading scores. O, High
Gleason score (8-10); 0, intermediate Gleason score (5-7); A,
low Gleason score (2-4).
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Figure 1 The univariate scattergrams of the BCDR (a) and PCa
volume (b) reveal quadratic increasing curved lines.
PCa volume (mm3)
Table I Distribution of PCa by volume and histological grading
scores
PCa volume range (mm3) High Intermediate Low Total
0-50 1 3 20* 24
51-100 1 3 10 14
101-200 2 4 8 14
Over 200 3 5 5 13
65
*X2-test, P<0.001. High, high-grade Pca (8-10 Gleason's grade);
Intermediate, intermediate grade Pca (5-7 Gleason's grade); Low,
low-grade Pca (2-4 Gleason's grade).
Table II Equations and parameters of the experimental regression
analysis of the correlation between the BCDR and PCa volume
(x>Z)y = L[I-e(-t<)],dy/dx = y(L-y)(x < Z)y = b
Parameter
Z 83.125 0.625
L 1.650 ± 0.025
y 0.675 ± 0.00025
a 10.000 2.5
b 0.336 0.012
x, PCa volume; y, BCDR; Z, statistical judgement value of x.
Table III Analysis of variance of the BCDR at PCa volume of less
than 83.125 mm3
Source f S V
m 1 3.503137 3.503137
x 1 0.000921 0.000921
e 29 0.133637 0.004608 NS
Total 31 3.637695
f, degree of freedom; S, sum percentage; V, variance; m, mean
value; x, tendency of the first degree; e, error.
Figure 3 The biviarate scattergram between BCDR and PCa
volume less than 250 mm3. The correlation between BCDR and
PCa volume can be divided at PCa volume of
83.125 ± 0.625 mm3 into two distinct phenotypic stages by experi-
mental regression analysis (see also Tables I and II).
mean value of the BCDR was 0.336 ± 0.012 mm3 (Tables II
and III).
Discussion
There is increased public awareness and more frequent diag-
noses of prostatic carcinoma (PCa), but we know that many
such tumours are clinically insignificant localised lesions.
Indeed, it has been reported that up to 30% of prostates
removed at autopsy have incidental localised carcinomas,
so-called 'latent PCa' (Scardino, 1989). Whether these latent
PCa would have become clinically apparent had the patient
continued alive, or whether only certain tumours become
more aggressive and, consequently, clinically apparent, is not
known with certainty.
Tumour blood capillaries are important components in the
support of tumour growth, and growth of a malignant
tumour beyond a certain size requires angiogenesis. It has
been postulated that tumour growth takes place in two
stages-prevascular and vascular (Revesz et al., 1989; Barnhill
et al., 1992; Bosari et al., 1992; Brawer et al., 1992; Folkman,
1992; Macchiarini et al., 1992; Bigler et al., 1993), with
initiation of angiogenesis is providing an important step in
cancer development.
The statistical analysis presented here revealed that correla-
tion between tumour angiogenesis and volume of latent PCa
could be divided into two distinct stages. The angiogenic
phenotype in latent PCa first appeared when tumour volumes
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reached 83 mm3. On the other hand, small PCa, especially
those less than 83 mm3 volume, showed low levels of the
angiogenesis, and it seemed that these PCa might be 'early'
indolent carcinoma without the tumour angiogenic
phenotype.
Thereafter, the transformed tumour cells presumably were
capable of producing angiogenic factors and growing. The
present study suggested the possibility of two types of latent
PCa, one putatively indolent and the other aggressive, the
latter perhaps arising from the former. Although it is very
likely that increased capillary density represents one specific
aspect of a complex pattern of changes in the multistep
progression of PCa, the present study suggests that PCas
with volume of more than 83 mm3 already have a more
dangerous phenotype for aggressive tumour growth.
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